Skip to main content

Animations

MJFF Publications

2601 - 2610 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2020
  • 2020
  • 2022
  • 2021
  • 2022
  • Summary Details
    RESTRICTED
    Title: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Issue Overview
    Journal Name: Continuum
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1d
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Issue Overview
    Journal Name: Continuum
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Severe Case of Lupus Cerebritis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8a
    Citation Count: 1
  • Summary Details
    OPEN
    Title: GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning
    Journal Name: IEEE/ACM Transactions on Computational Biology and Bioinformatics
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1109/tcbb.2020.3003830
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Structural and Textual Information Fusion for Symptom and Disease Representation Learning
    Journal Name: IEEE Transactions on Knowledge and Data Engineering
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/tkde.2020.3039469
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MS
    Journal Name: Biomedical Chromatography
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/bmc.5423
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Preferences for Communication About End‐of‐Life Care in Atypical Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28633
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29132
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.